Skip to main content

NCBiotech News

  • Raleigh biotechnology company Agile Sciences has landed a $1.5 million National Institutes of Health grant to help develop its cystic fibrosis therapy derived from sea sponges.
  • North Carolina’s life science community can now get inside information on funding and business strategy at the NCBiotech library, via its PitchBook private equity and venture capital database.
  • if you could use some funding help to commercialize a life science idea, you still have a couple of days to apply for a chance to pitch your company story to investors and colleagues at the 16th annual Southeast BIO Investor & Partnering Forum.
  • The Fresenius Kabi pharmaceutical plant in Raleigh is being purchased by Danish drug company Xellia Pharmaceuticals for an undisclosed sum, but with plans to expand at its first United States site.
  • Weekly Grant Funding Opportunities
  • Each of the 28 companies and institutions that stepped up to help pay for the North Carolina Pavilion at BIO 2014, as well as the Friends of NC who provided food and beverages for a highly popular opening-day reception, deserve the gratitude of all 66,000-plus people who work in the life sciences statewide.
  • Bayer CropScience has continued to secure North Carolina’s global agricultural biotechnology leadership by announcing the start of another $30 million expansion on its Research Triangle Park campus.
  • Weekly Grant Funding Opportunities
  • Biogen Idec’s Machelle Sanders, GlaxoSmithKline’s David Stewart and BTEC's Nathaniel Hentz discussed the importance of North Carolina's workforce talent preparation to the state's biomanufacturing leadership, on a panel at the BIO International Convention.
  • Executives of Durham development-stage biopharmaceutical company Parion Sciences collected a Tibbetts Award from the U.S. Small Business Administration at a recent ceremony on the steps of the White House to recognize the company's ability to turn federal research grants into technical innovations with economic impact. Parion is an NCBiotech portfolio company.
  • Life science jobs in North Carolina have increased 7 percent since 2007, to more than 66,000 by the end of 2012. And despite the overall economic struggle to claw back from the Great Recession, life science salaries in the state rose nearly 13 percent, to $82,000, says a new report from Battelle,
  • Daniel Ren of Cary was among this year’s top 15 North American high school students in the 2014 International BioGENEius Challenge at the BIO International Convention in San Diego.
  • Morrisville-based Gentris, which provides storage and testing services to research laboratories, has received a $4.75 million buy-out offer from New Jersey-based Cancer Genetics, Inc. (CGI).
  • Just two days after his company’s promising cancer-fighting technology is featured on WRAL, Raleigh’s CBS affiliate, Heat Biologics CEO Jeff Wolf is participating in a panel discussion in the North Carolina Pavilion at the BIO International Convention in San Diego.
  • Weekly Grant Funding Opportunities
  • If dengue, chikungunya, West Nile and about 200 other mosquito-carried viruses have you concerned, you're in luck. North Carolina is the world vaccine leader. This top-tier bioscience state goes viral when vaccines are the topic.
  • The United Nations projects that by 2050, we’ll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from? It’s a question that North Carolina companies are researching in earnest. 
  • A $1.8 million federal grant has been awarded to the City of Clinton to help pay for water and sewer hookups to a planned $200 million investment: a 20-million-gallon-a-year cellulosic biofuel refinery in the Sampson County community.
  • North Carolina reigns, after more than three decades of growth and change in the industry, as the CRO epicenter of the world.
  • Seven years after construction began on the $1 billion Novartis Holly Springs cell culture vaccine manufacturing facility, federal regulators have approved the factory’s output of the revolutionary Flucelvax flu vaccine for sale in the United States.


Subscribe to News & Events